These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 14651477)
1. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149. Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477 [TBL] [Abstract][Full Text] [Related]
2. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors. Andersen B; Westergaard N Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Zibrova D; Grempler R; Streicher R; Kauschke SG Biochem J; 2008 Jun; 412(2):359-66. PubMed ID: 18298402 [TBL] [Abstract][Full Text] [Related]
5. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes. Latsis T; Andersen B; Agius L Biochem J; 2002 Nov; 368(Pt 1):309-16. PubMed ID: 12186629 [TBL] [Abstract][Full Text] [Related]
6. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors. Gregus Z; Németi B Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424 [TBL] [Abstract][Full Text] [Related]
8. Regulation and function of the muscle glycogen-targeting subunit of protein phosphatase 1 (GM) in human muscle cells depends on the COOH-terminal region and glycogen content. Lerín C; Montell E; Nolasco T; Clark C; Brady MJ; Newgard CB; Gómez-Foix AM Diabetes; 2003 Sep; 52(9):2221-6. PubMed ID: 12941760 [TBL] [Abstract][Full Text] [Related]
9. Expression and glycogenic effect of glycogen-targeting protein phosphatase 1 regulatory subunit GL in cultured human muscle. Montori-Grau M; Guitart M; Lerin C; Andreu AL; Newgard CB; García-Martínez C; Gómez-Foix AM Biochem J; 2007 Jul; 405(1):107-13. PubMed ID: 17555403 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression. Schnier JB; Nishi K; Monks A; Gorin FA; Bradbury EM Biochem Biophys Res Commun; 2003 Sep; 309(1):126-34. PubMed ID: 12943673 [TBL] [Abstract][Full Text] [Related]
11. Effects in skeletal muscle. Young A Adv Pharmacol; 2005; 52():209-28. PubMed ID: 16492548 [TBL] [Abstract][Full Text] [Related]
12. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Baker DJ; Greenhaff PL; MacInnes A; Timmons JA Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853 [TBL] [Abstract][Full Text] [Related]
13. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). Suh SW; Bergher JP; Anderson CM; Treadway JL; Fosgerau K; Swanson RA J Pharmacol Exp Ther; 2007 Apr; 321(1):45-50. PubMed ID: 17251391 [TBL] [Abstract][Full Text] [Related]
14. Role of glycogen content in insulin resistance in human muscle cells. Litherland GJ; Morris NJ; Walker M; Yeaman SJ J Cell Physiol; 2007 May; 211(2):344-52. PubMed ID: 17167773 [TBL] [Abstract][Full Text] [Related]
15. Glycogen depletion rather than glucose 6-P increments controls early glycogen recovery in human cultured muscle. Montell E; Arias A; Gómez-Foix AM Am J Physiol; 1999 May; 276(5):R1489-95. PubMed ID: 10233043 [TBL] [Abstract][Full Text] [Related]
16. Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase. Halse R; Fryer LG; McCormack JG; Carling D; Yeaman SJ Diabetes; 2003 Jan; 52(1):9-15. PubMed ID: 12502487 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycogen synthesis by increased lipid availability is associated with subcellular redistribution of glycogen synthase. Taylor AJ; Ye JM; Schmitz-Peiffer C J Endocrinol; 2006 Jan; 188(1):11-23. PubMed ID: 16394171 [TBL] [Abstract][Full Text] [Related]
18. Regulation of glycogen metabolism in gills and liver of the euryhaline tilapia (Oreochromis mossambicus) during acclimation to seawater. Chang JC; Wu SM; Tseng YC; Lee YC; Baba O; Hwang PP J Exp Biol; 2007 Oct; 210(Pt 19):3494-504. PubMed ID: 17873003 [TBL] [Abstract][Full Text] [Related]
19. Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors. Ercan-Fang N; Taylor MR; Treadway JL; Levy CB; Genereux PE; Gibbs EM; Rath VL; Kwon Y; Gannon MC; Nuttall FQ Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E366-72. PubMed ID: 15797986 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme. Freeman S; Bartlett JB; Convey G; Hardern I; Teague JL; Loxham SJ; Allen JM; Poucher SM; Charles AD Br J Pharmacol; 2006 Nov; 149(6):775-85. PubMed ID: 17016495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]